Industry Symposia
Industry Symposia presented at Lunch
PLEASE NOTE: All Symposia are produced independently of Princess Margaret and Sunnybrook Hospital's and are supported by educational grants from industry.
There is no cost to attend Industry Symposia but seating is limited!
You must be a Registered Delegate of Toronto Cancer Conference to participate in Symposium opportunities
Thursday November 22
12:10pm - 1:25pm
Learning Objectives:
- Review the recent advances in the management of HER2-positive breast cancer
- Discuss current treatment paradigm and challenges
- Review new approaches (i.e. T-DM1, pertuzumab, Subcutaneous trastuzumab) for patients with HER2-positive breast cancer
Sunil Verma, MD MSEd FRCPC
Medical Oncologist, Sunnybrook Odette Cancer Centre
[Read More]
| Supported by an educational grant from Hoffmann-La Roche Limited --------------------------------------------------------------- |
 |
Friday November 23
12:40pm - 1:55pm
The Changing Paradigm in the Multidisciplinary Management of Patients with mCRC
Patients with mCRC are living longer as new tratment becomes available and more inttricate procedures are salso offered. Multidicilinary manmagement from the start is paramount as a foundational reality between HPB Surgeons, Medial and Surgical Oncologists, Radiation Oncologists and other Allied Health.
Learning Objectives:
- Discuss optimizing multidisciplinary management of liver-limited Colorectal Liver Metastases (CLM)
- Review recent evidence that influences the sequence of treatment for patients with metastatic colorectal cancer
- Review treatment options in different patient types with liver-limited CLM
Yoo-joung Ko, MD MMSC SM FRCP(C)
Sean P. Cleary, BScH MD MSc MPH FRCSC| Supported by an educational grant from Hoffmann-La Roche Limited --------------------------------------------------------------- |
|